135 related articles for article (PubMed ID: 1678923)
1. Long-term efficacy and safety of terazosin alone and in combination with other antihypertensive agents.
Cohen JD
Am Heart J; 1991 Sep; 122(3 Pt 2):919-25. PubMed ID: 1678923
[TBL] [Abstract][Full Text] [Related]
2. Combination antihypertensive therapy with terazosin and other antihypertensive agents: results of clinical trials.
Pool JL
Am Heart J; 1991 Sep; 122(3 Pt 2):926-31. PubMed ID: 1678924
[TBL] [Abstract][Full Text] [Related]
3. Long-term experience with terazosin for treatment of mild to moderate hypertension.
Mersey JH
Am J Med; 1986 May; 80(5B):68-72. PubMed ID: 2872810
[TBL] [Abstract][Full Text] [Related]
4. Experience with terazosin administered in combination with other antihypertensive agents.
Chrysant SG
Am J Med; 1986 May; 80(5B):55-61. PubMed ID: 2872808
[TBL] [Abstract][Full Text] [Related]
5. Long-term efficacy and safety of terazosin.
Cohen J
J Clin Pharmacol; 1993 Mar; 33(3):272-8. PubMed ID: 8096524
[No Abstract] [Full Text] [Related]
6. The effects of terazosin and methyclothiazide on blood pressure and serum lipids.
Luther RR; Glassman HN; Estep CB; Maurath CJ; Jordan DC
Am Heart J; 1989 Apr; 117(4):842-7. PubMed ID: 2564723
[TBL] [Abstract][Full Text] [Related]
7. Comparative trials of terazosin with other antihypertensive agents.
Ruoff G
Am J Med; 1986 May; 80(5B):42-8. PubMed ID: 2872806
[TBL] [Abstract][Full Text] [Related]
8. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings.
Itskovitz HD
Clin Ther; 1994; 16(3):490-504. PubMed ID: 7923316
[TBL] [Abstract][Full Text] [Related]
9. Terazosin, a new selective alpha 1-adrenergic blocking agent. Results of long-term treatment in patients with essential hypertension.
Luther RR; Glassman HN; Estep CB; Schmitz PJ; Horton JK; Jordan DC
Am J Hypertens; 1988 Jul; 1(3 Pt 3):237S-240S. PubMed ID: 2901267
[TBL] [Abstract][Full Text] [Related]
10. Effects of oral and intravenous terazosin and head-up tilt on blood pressure responses in patients with hypertension.
Achari R; Hosmane B; Linnen P; Cavanaugh J; Baroldi P; Cohen A
J Clin Pharmacol; 1998 Jun; 38(6):545-53. PubMed ID: 9650545
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the safety and efficacy of once-daily terazosin versus twice-daily prazosin for the treatment of mild to moderate hypertension.
Deger G
Am J Med; 1986 May; 80(5B):62-7. PubMed ID: 2872809
[TBL] [Abstract][Full Text] [Related]
12. The safety and efficacy of terazosin in the treatment of essential hypertension in blacks.
Saunders E
Am Heart J; 1991 Sep; 122(3 Pt 2):936-42. PubMed ID: 1678925
[TBL] [Abstract][Full Text] [Related]
13. A multicentre, hospital study of the efficacy and safety of terazosin and its effects on the plasma cholesterol levels of patients with essential hypertension.
Lytle TB; Coles SJ; Waite MA
J Clin Pharm Ther; 1991 Aug; 16(4):263-73. PubMed ID: 1682328
[TBL] [Abstract][Full Text] [Related]
14. Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in essential hypertension.
Titmarsh S; Monk JP
Drugs; 1987 May; 33(5):461-77. PubMed ID: 2885169
[TBL] [Abstract][Full Text] [Related]
15. Comparison of antihypertensive and lipid actions of terazosin and atenolol in essential hypertension.
Silke B; Guy S; Humphreys JE
J Hum Hypertens; 1992 Jun; 6(3):221-5. PubMed ID: 1352828
[TBL] [Abstract][Full Text] [Related]
16. The relationship between terazosin dose and blood pressure response in hypertensive patients.
Achari R; Hosmane B; Bonacci E; O'Dea R
J Clin Pharmacol; 2000 Oct; 40(10):1166-72. PubMed ID: 11028256
[TBL] [Abstract][Full Text] [Related]
17. Safety assessment of terazosin in the treatment of patients with symptomatic benign prostatic hyperplasia: a combined analysis.
Lowe FC
Urology; 1994 Jul; 44(1):46-51. PubMed ID: 7518981
[TBL] [Abstract][Full Text] [Related]
18. Alpha 2-agonist versus alpha 1-antagonist in mild-to-moderate hypertension: comparison of transdermal clonidine and terazosin monotherapies.
Harris SI; Alvarez C
Am J Ther; 1997 Jan; 4(1):9-15. PubMed ID: 10423584
[TBL] [Abstract][Full Text] [Related]
19. Terazosin in benign prostatic hyperplasia: effects on blood pressure in normotensive and hypertensive men.
Kirby RS
Br J Urol; 1998 Sep; 82(3):373-9. PubMed ID: 9772873
[TBL] [Abstract][Full Text] [Related]
20. [Effects of terazosine and atenolol on serum lipids in essential hypertension].
Bur A; Woisetschläger C; Herkner H; Derhaschnig U; Quehenberger P; Hirschl MM
Z Kardiol; 2002 Sep; 91(9):685-92. PubMed ID: 12448067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]